Complement facilitates early prion pathogenesis (original) (raw)

• Hill, A.F., Zeidler, M., Ironside, J. & Collinge, J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99 (1997).
  Article CAS Google Scholar
• Fraser, H. & Dickinson, A.G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462–463 (1970).
  Article CAS Google Scholar
• Klein, M.A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687–690 (1997).
  Article CAS Google Scholar
• Klein, M.A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429–1433 (1998).
  Article CAS Google Scholar
• Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257–1259 (2000).
  Article CAS Google Scholar
• Kitamoto, T., Muramoto, T., Mohri, S., Dohura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J.Virol. 65, 6292–6295 (1991).
  CAS PubMed PubMed Central Google Scholar
• Botto, M. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56–59 (1998).
  Article CAS Google Scholar
• Taylor, P.R. et al. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273, 1699–1704 (1998).
  Article CAS Google Scholar
• Molina, H. et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93, 3357–3361 (1996).
  Article CAS Google Scholar
• Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423–426 (1991).
  Article CAS Google Scholar
• Park, S.Y. et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102, 1229–1238 (1998).
  Article CAS Google Scholar
• Takai, T., Ono, M., Hikida, M., Ohmori, H. & Ravetch, J.V. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379, 346–349 (1996).
  Article CAS Google Scholar
• Hazenbos, W.L. et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc γ xsRIII (CD16) deficient mice. Immunity 5, 181–188 (1996).
  Article CAS Google Scholar
• Szakal, A.K. & Hanna, M.G. Jr. The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. Exp. Mol. Pathol. 8, 75–89 (1968).
  Article CAS Google Scholar
• Carroll, M.C. CD21/CD35 in B cell activation. Semin. Immunol. 10, 279–286 (1998).
  Article CAS Google Scholar
• Yamakawa, M. & Imai, Y. Complement activation in the follicular light zone of human lymphoid tissues. Immunology 76, 378–384 (1992).
  CAS PubMed PubMed Central Google Scholar
• Ahearn, J.M. et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251–262 (1996).
  Article CAS Google Scholar
• Büeler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19–30 (1994).
  Article Google Scholar
• Croix, D.A. et al. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183, 1857–1864 (1996).
  Article CAS Google Scholar
• Ebenbichler, C.F. et al. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med . 174, 1417–1424 (1991).
  Article CAS Google Scholar
• Klickstein, L.B., Barbashov, S.F., Liu, T., Jack, R.M. & Nicholson-Weller, A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7, 345–355 (1997).
  Article CAS Google Scholar
• Fischer, M.B. et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582–585 (1998).
  Article CAS Google Scholar
• Wu, X. et al. Impaired affinity maturation in Cr2−/− mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165, 3119–3127 (2000).
  Article CAS Google Scholar
• Hill, A.F. et al. Investigation of variant Creutzfeldt–Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183–189 (1999).
  Article CAS Google Scholar
• Nemazee, D.A. & Burki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562–566 (1989).
  Article CAS Google Scholar
• Sitia, R., Neuberger, M.S. & Milstein, C. Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J. 6, 3969–3977 (1987).
  Article CAS Google Scholar
• Seiler, P. et al. Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J. Virol. 72, 2253–2258 (1998).
  CAS PubMed PubMed Central Google Scholar
• Büeler, H.R. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347 (1993).
  Article Google Scholar
• Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255–1264 (1996).
  Article CAS Google Scholar
• Prusiner, S.B. et al. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol. 11, 353–358 (1982).
  Article CAS Google Scholar
• Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339–343 (1996).
  Article CAS Google Scholar